Scientists investigate why vaginal estrogen only works for half of women with recurrent UTIs
NCT ID NCT05551949
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looked at 27 postmenopausal women with frequent urinary tract infections (UTIs) to understand why vaginal estrogen therapy prevents UTIs in only about half of them. Researchers examined changes in bacteria in the vagina and bladder, as well as immune responses, before and after treatment. The goal is to use these findings to develop better prevention strategies for this common condition.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CYSTITIS RECURRENT are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Johns Hopkins Bayview Medical Center
Baltimore, Maryland, 21224, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can better school toilets and peer support boost girls' health and grades? a madagascar trial aims to find out.
- New symptom diaries aim to improve daily tracking of recurrent UTIs, especially for seniors
- Could fewer antibiotics be better for older women with urinary symptoms?
- Could a probiotic plus smart antibiotic use end the cycle of recurrent UTIs in children?
- Antibiotic levels in breast milk under the microscope
- Can antibiotic wash and suction stop Post-Surgery infections?